连续性静脉-静脉血液透析滤过联合HA380血液灌流治疗15例热射病合并多器官功能障碍综合征的疗效观察
该研究为回顾性观察性研究,纳入2022年7—9月湖北医药学院附属随州中心医院ICU收治的15例热射病合并MODS患者,均在重症综合管理策略基础上接受CVVHDF联合HA380血液灌流治疗。治疗后IL-6和SOFA评分逐步下降,第二次血液灌流后与入院时比较差异有统计学意义;PCT在第一次血液灌流后达峰值,第三次血液灌流后差异有统计学意义;Cr在第一次血液灌流后、Myo在第二次后、CK在第三次后较入院时显著改善。病程第5天WBC、PCT、IL-6及AST、CK、LDH、Cr、Myo、CK-MB、SOFA评分均较入院时明显改善。15例患者24小时生存率86.67%,24小时、7天和28天生存率均为73.33%。作者认为该联合方案是提高重症热射病抢救成功率、降低死亡率的有效手段。
要点
- 15例热射病合并MODS患者接受CVVHDF联合HA380血液灌流,第二次灌流后IL-6由入院时221.90(85.87, 425.90)ng/L降至48.37(15.36, 113.03)ng/L,SOFA由11.1±2.4降至8.3±3.3,均P<0.05。
- PCT在第一次血液灌流后达峰值12.51(6.07, 41.65)μg/L,第三次血液灌流后降至1.26(0.82, 5.40)μg/L,差异有统计学意义(P<0.05)。
- Cr在第一次血液灌流后由入院时110.80±31.13 μmol/L降至66.94±25.57 μmol/L(P<0.01),Myo在第二次后、CK在第三次后较入院时显著下降(均P<0.05)。
- 15例患者24小时生存率86.67%,24小时、7天和28天生存率均为73.33%;11例存活者平均机械通气101.8±22.0小时、CRRT 58.8±11.0小时、ICU住院6.3±1.0天、总住院14.6±5.2天。
- 作者认为CVVHDF联合HP HA380可有效改善器官功能、减轻炎症风暴,是提高重症热射病抢救率、降低死亡率的有效手段。
适用人群与场景
- 2022年7—9月湖北医药学院附属随州中心医院ICU收治的热射病合并MODS患者15例,其中男性10例、女性5例,平均年龄(64.5±11.5)岁,经典型热射病6例、劳力型热射病9例。
- 入院时GCS 3—8分,入ICU 12小时内SOFA评分9—17分,入ICU 24小时内APACHE II评分25—45分。
处置流程与药物剂量
- 全部15例患者在重症综合管理策略基础上接受CVVHDF联合HA380血液灌流治疗,共行3次血液灌流。
- 治疗期间于入院时、第一次血液灌流后、第二次血液灌流后、第三次血液灌流后及治疗第5天采集器官功能指标和炎症指标进行比较。
研究设计与关键结果
- 研究类型为回顾性观察性研究,样本量15例,单中心(湖北医药学院附属随州中心医院ICU),人群为热射病合并MODS患者,干预为CVVHDF联合HA380血液灌流,无对照组。
- 第二次血液灌流后IL-6由入院时221.90(85.87, 425.90)ng/L降至48.37(15.36, 113.03)ng/L,SOFA评分由11.1±2.4降至8.3±3.3,差异均有统计学意义(均P<0.05)。
- PCT在第一次血液灌流后达峰值12.51(6.07, 41.65)μg/L,第三次血液灌流后降至1.26(0.82, 5.40)μg/L,差异有统计学意义(P<0.05)。
- Cr在第一次血液灌流后由入院时110.80±31.13 μmol/L降至66.94±25.57 μmol/L(P<0.01)。
- Myo在第二次血液灌流后由入院时3000.00(293.00, 3000.00)μg/L降至490.90(164.98, 768.05)μg/L(P<0.05)。
- CK在第三次血液灌流后由入院时2107.0(729.0, 2449.0)U/L降至476.0(413.0, 922.0)U/L(P<0.05)。
- 病程第5天WBC、PCT、IL-6较入院时明显改善,AST、CK、LDH、Cr、Myo、CK-MB及SOFA评分较入院时明显纠正。
- 15例患者24小时生存率86.67%,24小时、7天和28天生存率均为73.33%;11例存活者平均机械通气时间(101.8±22.0)小时,平均CRRT时间(58.8±11.0)小时,平均ICU住院时间(6.3±1.0)天,平均总住院时间(14.6±5.2)天。
证据类型、等级与局限
- 证据类型:回顾性观察性研究;原文未给出证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,CVVHDF联合HP HA380治疗热射病合并MODS患者可有效改善器官功能、减轻炎症风暴,是提高重症热射病抢救率、降低死亡率的有效手段。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the clinical efficacy of continuous veno-venous hemodia-filtration (CVVHDF) combined with hemoperfusion (HP) HA380 in the treatment of heat stroke patients with multiple organ dysfunction syndrome (MODS).
METHODS: A retrospective and observational study was conducted. A total of 15 patients with heat stroke combined with MODS who were admitted to the department of intensive care unit (ICU) of Suizhou Central Hospital/Hubei University of Medicine from July to September 2022 were selected as the study objects. All 15 patients were treated with CVVHDF combined with HA380 based on the comprehensive management strategy for severe illness. Organ function indicators [including total bilirubin (TBil), aspartate aminotransferase (AST), creatine kinase (CK), lactate dehydrogenase (LDH), creatinine (Cr), cardiac troponin T (cTnT), myoglobin (Myo), MB isoenzyme of creatine kinase (CK-MB), sequential organ failure assessment (SOFA)] and inflammatory indicators [including white blood cell count (WBC), neutrophil count (NEU), C-reactive protein (CRP), procalcitonin (PCT), and interleukin-6 (IL-6)] were collected. The improvements of the above indexes at admission, after the first HP, after the second HP, after the third HP, and on the 5th day of treatment were compared. Combined with the clinical outcome of patients, the comprehensive efficacy of CVVHDF combined with HA380 in the treatment of severe heat radiation disease was evaluated.
RESULTS: There were 10 males and 5 females among the 15 patients. The average age was (64.5±11.5) years old. There were 6 cases of classical heat stroke and 9 cases of exertional heat stroke. Glasgow coma scale (GCS) was 3-8 at admission; SOFA score was 9-17 within 12 hours after admission; acute physiology and chronic health evaluation II (APACHE II) was 25-45 within 24 hours after admission. After treatment, the IL-6 level and SOFA score gradually decreased, and there were significant differences in the decrease after the second HP compared to admission [IL-6 (ng/L): 48.37 (15.36, 113.03) vs. 221.90 (85.87, 425.90), SOFA: 8.3±3.3 vs. 11.1±2.4, both P < 0.05]. The PCT level reached its peak after the first HP [12.51 (6.07, 41.65) μg/L], and then gradually decreased, and the difference was statistically significant after the third HP [1.26 (0.82, 5.40) μg/L, P < 0.05]. Compared those at admission, Cr level significantly improved after the first HP (μmol/L: 66.94±25.57 vs. 110.80±31.13, P < 0.01), Myo significantly decreased after the second HP [μg/L: 490.90 (164.98, 768.05) vs. 3 000.00 (293.00, 3 000.00), P < 0.05], After the third HP, the CK level also showed significant improvement [U/L: 476.0 (413.0, 922.0) vs. 2 107.0 (729.0, 2 449.0), P < 0.05]. After CVVHDF combined with 3 times HP treatment, the patient's inflammatory response was gradually controlled and organ function gradually recovered. On the 5th day of the disease course, WBC, PCT and IL-6 levels were significantly improved compared to admission, and AST, CK, LDH, Cr, Myo, CK-MB, and SOFA score were significantly corrected compared with those on admission. The 24-hour survival rate of 15 patients was 86.67%, and the 24-hour, 7-day and 28-day survival rates were both as high as 73.33%. The average mechanical ventilation time of 11 surviving patients was (101.8±22.0) hours, the average continuous renal replacement therapy (CRRT) time was (58.8±11.0) hours, the average length of ICU stay was (6.3±1.0) days, and the average total hospitalization was (14.6±5.2) days.
CONCLUSIONS: CVVHDF combined with HP HA380 in the treatment of heat stroke patients with MODS can effectively improve organ function and alleviate the inflammatory storm, which is an effective means to improve the rescue rate and reduce the mortality of severe heat stroke patients.
参考来源
- Huang Y, Long L, Huang Q, et al. [Observation on the efficacy of continuous veno-venous hemodia-filtration combined with hemoperfusion HA380 in the treatment of 15 cases of heat stroke with multiple organ dysfunction syndrome]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38845502. doi:10.3760/cma.j.cn121430-20230728-00561
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。